학술논문
Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey.
Document Type
Article
Author
Bechman, Katie; Cook, Emma S.; Dand, Nick; Yiu, Zenas Z.N.; Tsakok, Teresa; Meynell, Freya; Coker, Bolaji; Vincent, Alexandra; Bachelez, Herve; Barbosa, Ines; Brown, Matthew A.; Capon, Francesca; Contreras, Claudia R.; De La Cruz, Claudia; Meglio, Paola Di; Gisondi, Paolo; Jullien, Denis; Kelly, Jade; Lambert, Jo; Lancelot, Camille
Source
Subject
*VACCINE hesitancy
*VACCINATION
*COVID-19 pandemic
*PSORIASIS
*DERMATOLOGISTS
*
*
*
*
Language
ISSN
0007-0963
Abstract
This finding supports current limited data on vaccine hesitancy among patients with psoriasis.6 In contrast to a prior report in psoriasis,6 but in keeping with general population trends,4 hesitancy was more prominent among younger people. PsoProtect I Me i was updated 1 year following its launch to include COVID-19 vaccine hesitancy and questions regarding access to care, hence the current sample may not be representative of the original larger sample.7 Taken together, these data indicate that only a minority of individuals with psoriasis have vaccine hesitancy hence our findings are promising for current and future COVID-19 vaccine uptake. (d) Association between disrupted access to psoriasis care and COVID-19 vaccine hesitancy. gl In an unadjusted logistic regression model, strongly agreeing that psoriasis care was disrupted, was associated with vaccine hesitancy [compared with strongly disagreeing; odds ratio (OR) 2-97, 95% confidence interval (CI) 1-23-7-13, I P i = 0-015]. Dear Editor, COVID-19 vaccines protect against severe COVID-19 outcomes; however, many individuals remain unvaccinated.1,2 Vaccine hesitancy (delayed acceptance or refusal of vaccination despite service availability) threatens public health. [Extracted from the article]